StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mylan's (MYL) EpiPen Saga Could Add More Supply Chain Volatility Moving Forward - Evercore
August 25, 2016 11:46 AM
Evercore ISI affirms Mylan (Nasdaq: MYL) with a Hold rating and $49 price target amid today's EpiPen cost-adjustment news.The firm ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Mylan (MYL) Shares Move to Session Lows
August 25, 2016 3:02 PM
Buy CVS Health (CVS) on EpiPen-Related Weakness - Leerink
August 25, 2016 11:30 AM
Elijah Cummings Says Mylan's (MYL) Meager Discount Merely 'PR Move'
August 25, 2016 10:42 AM
Mylan's (MYL) Steps on EpiPen Do Not Go Far Enough - Wells Fargo's Maris
August 25, 2016 10:33 AM
Mylan (MYL) calls active after cutting patient cost of EpiPen Auto-Injectors
August 25, 2016 10:03 AM
Options with increasing volume: NYMX MYL ULTA
August 25, 2016 9:43 AM
Wall St. slips on healthcare, consumer names; Fed eyed
August 25, 2016 9:10 AM
Mylan (MYL) CEO says healthcare bubble 'going to burst'
August 25, 2016 8:37 AM
Mylan (MYL) volatile amid CEO interview on CNBC
August 25, 2016 8:34 AM
Mylan (MYL) Gains Early After Taking Action on EpiPen Pricing
August 25, 2016 7:51 AM
